Bottom line
MSGRX vs SCHA: the short answer
MSGRX (Meridian Small Cap Growth Fund) and SCHA (Schwab U.S. Small-Cap ETF) are both mutual funds.
But SCHA is far broader, holding 1,708 positions to 100 for MSGRX, so beyond the top names it adds exposure MSGRX doesn't have.
SCHA is cheaper at 0.03% vs 1.11% — a difference of $108 a year per $10,000 invested.
Over five years, SCHA returned +8.0% a year vs +0.5% for MSGRX (reporting dates differ).
Updated Nov 19, 2026
MSGRX vs SCHA side by side
| MSGRX | SCHA | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Meridian | Schwab |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 1.11% | 0.03% |
| Annual cost per $10k | $111 | $3 |
| 10-yr cost on $10k (prospectus) | $1,511 | $39 |
| Max front load | 0% | None |
| 12b-1 fee | — | — |
| 1-yr return | −1.1% | +11.1% |
| 5-yr return (annualized) | +0.5% | +8.0% |
| 10-yr return (annualized) | +8.9% | +8.0% |
| Best quarter | — | +30.8% |
| Worst quarter | — | −31.6% |
| Net assets (fund) | $272.9M | $22.8B |
| Number of holdings | 100 | 1,708 |
| Portfolio turnover | 62% | 11% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MSGRX and SCHA share none of their top holdings.
MSGRX top 10
- Stit Govt And Agency Inst — 6.34%
- Axogen Inc — 3.19%
- Federal Signal Corp — 2.33%
- Hinge Health Inc — 2.26%
- Goldman Sachs Trust — 2.17%
- Veracyte Inc — 2.11%
- Consensus Cloud Solutions Inc — 2.07%
- Apartment List Inc. Series D Preferred Stock — 2.02%
- Definium Therapeutics Inc — 1.99%
- Spx Technologies Inc — 1.98%
SCHA top 10
- Sandisk Corp/DE — 5.28%
- State Street Institutional US Government Money Market Fund — 1.65%
- Lumentum Holdings Inc — 1.29%
- Revolution Medicines Inc — 0.65%
- Sterling Infrastructure Inc — 0.56%
- ATI Inc — 0.50%
- MACOM Technology Solutions Holdings Inc — 0.50%
- Nextpower Inc — 0.49%
- MKS Inc — 0.46%
- Coeur Mining Inc — 0.42%
FAQ
What is the difference between MSGRX and SCHA?
Which is cheaper, MSGRX or SCHA?
Should I own both MSGRX and SCHA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.